These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12200011)

  • 1. [Pharmacokinetic interactions between methadone and antiretroviral medication in HIV positive patients].
    Pérez Pons JC; Jornet Montaña S; Bonet Esteve A
    Med Clin (Barc); 2002 Jul; 119(6):224-9. PubMed ID: 12200011
    [No Abstract]   [Full Text] [Related]  

  • 2. The pharmacokinetics of methadone following co-administration with a lamivudine/zidovudine combination tablet in opiate-dependent subjects.
    Rainey PM; Friedland GH; Snidow JW; McCance-Katz EF; Mitchell SM; Andrews L; Lane B; Jatlow P
    Am J Addict; 2002; 11(1):66-74. PubMed ID: 11876585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of nonadherence to HIV-related medication regimens during methadone stabilization.
    Avants SK; Margolin A; Warburton LA; Hawkins KA; Shi J
    Am J Addict; 2001; 10(1):69-78. PubMed ID: 11268829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences among HIV-positive methadone maintenance patients enrolled in a medication adherence trial.
    Haug NA; Sorensen JL; Lollo ND; Gruber VA; Delucchi KL; Hall SM
    AIDS Care; 2005 Nov; 17(8):1022-9. PubMed ID: 16176898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication adherence strategies for drug abusers with HIV/AIDS.
    Sorensen JL; Mascovich A; Wall TL; DePhilippis D; Batki SL; Chesney M
    AIDS Care; 1998 Jun; 10(3):297-312. PubMed ID: 9828973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and nelfinavir.
    McCance-Katz EF; Rainey PM; Smith P; Morse G; Friedland G; Gourevitch M; Jatlow P
    Am J Addict; 2004; 13(2):163-80. PubMed ID: 15204667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methadone is poorly removed by haemodialysis.
    Furlan V; Hafi A; Dessalles MC; Bouchez J; Charpentier B; Taburet AM
    Nephrol Dial Transplant; 1999 Jan; 14(1):254-5. PubMed ID: 10052536
    [No Abstract]   [Full Text] [Related]  

  • 8. [The medical duty of confidentiality with patients on methadone].
    Blank JH
    Dtsch Med Wochenschr; 1996 Mar; 121(11):351-4. PubMed ID: 8681726
    [No Abstract]   [Full Text] [Related]  

  • 9. No differences in quality of life between men and women undergoing HIV antiretroviral treatment. Impact of demographic, clinical and psychosocial factors.
    Perez IR; Olry de Labry Lima A; del Castillo LS; Bano JR; Ruz MA; del Arco Jimenez A
    AIDS Care; 2009 Aug; 21(8):943-52. PubMed ID: 20024750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone-substitution and driving ability.
    Rössler H; Battista HJ; Deisenhammer F; Günther V; Pohl P; Prokop L; Riemer Y
    Forensic Sci Int; 1993 Nov; 62(1-2):63-6. PubMed ID: 8300036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes of HIV-positive women toward zidovudine therapy during pregnancy.
    J Adv Nurs; 2002 Sep; 39(5):410-1. PubMed ID: 12229862
    [No Abstract]   [Full Text] [Related]  

  • 12. Predictors of accessing antiretroviral therapy among HIV-positive drug users in China's National Methadone Maintenance Treatment Programme.
    Zhao Y; Shi CX; McGoogan JM; Rou K; Zhang F; Wu Z
    Addiction; 2015 Jan; 110 Suppl 1(Suppl 1):40-50. PubMed ID: 25533863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response relationship between methadone dose and adherence to antiretroviral therapy among HIV-positive people who use illicit opioids.
    Lappalainen L; Nolan S; Dobrer S; Puscas C; Montaner J; Ahamad K; Dong H; Kerr T; Wood E; Milloy MJ
    Addiction; 2015 Aug; 110(8):1330-9. PubMed ID: 25940906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug interactions of methadone with CNS-active agents].
    Moreno Brea MR; Rojas Corrales O; Gibert-Rahola J; Micó JA
    Actas Esp Psiquiatr; 1999; 27(2):103-10. PubMed ID: 10380152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ageing with HIV: medication use and risk for potential drug-drug interactions.
    Marzolini C; Back D; Weber R; Furrer H; Cavassini M; Calmy A; Vernazza P; Bernasconi E; Khoo S; Battegay M; Elzi L;
    J Antimicrob Chemother; 2011 Sep; 66(9):2107-11. PubMed ID: 21680580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methadone maintenance: making it better.
    Zador D
    Addiction; 2007 Mar; 102(3):350-1. PubMed ID: 17298640
    [No Abstract]   [Full Text] [Related]  

  • 17. [Substitution treatments in Geneva].
    Feldman N; Mino A
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():31-3. PubMed ID: 7880011
    [No Abstract]   [Full Text] [Related]  

  • 18. Methadone prescribing in general practice.
    Lindsay JI
    Br J Gen Pract; 1999 Feb; 49(439):145. PubMed ID: 10326274
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antiretroviral therapy in pregnant women with HIV].
    Niemiec KT; Horban A; Chazan B; Firlag-Burkacka E
    Ginekol Pol; 1998 Nov; 69(11):820-6. PubMed ID: 10337075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undefined duration of opiate withdrawal induced by efavirenz in drug users with HIV infection and undergoing chronic methadone treatment.
    Boffito M; Rossati A; Reynolds HE; Hoggard PG; Back DJ; Di Perri G
    AIDS Res Hum Retroviruses; 2002 Mar; 18(5):341-2. PubMed ID: 11897035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.